Discover a study validating a disease-specific quality-of-life tool for hidradenitis suppurativa, confirming its reliability, ...

Panelists discuss the critical importance of early biologic therapy initiation in hidradenitis suppurativa to prevent irreversible tissue damage, reduce disease burden, and overcome socioeconomic and ...

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

We came across a bullish thesis on MoonLake Immunotherapeutics on Valueinvestorsclub.com by skimmer610. In this article, we ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing hidradenitis suppurativa severity and pain, especially in patients with obesity.

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

GLP-1 RA therapy reduces hidradenitis suppurativa severity, flares, symptoms, and BMI in patients with hidradenitis ...

Hidradenitis Suppurativa Market Size was USD ~1,400 million in the 7MM in 2023. Management involves antibiotics, surgery, and ...

Hidradenitis suppurativa patients face higher depression and anxiety risks, but biologic treatments may reduce these mental ...

Hidradenitis suppurativa is usually a clinical diagnosis, meaning doctors can determine if you have it after a physical exam. "When patients come in, we can usually tell right away whether they ...

1. Hidradenitis suppurativa can be emotionally exhausting. Living with a condition that affects every aspect of your life, including how you dress or your ability to work out, can feel burdensome ...